The availability of a novel predictive biomarker in diabetes care could have benefits for patients, payers, and pharma.
Ralph McDade, PhD
Advertisement
Articles by Ralph McDade, PhD
Advertisement
Latest Updated Articles
- Evidence for the Benefit of Targeted Proteomics in the Era of the "Big Data" Approach
Published: March 18th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Promises and Pitfalls of AI in Health Care
2
SCRI’s Vivek Subbiah, MD, Highlights Trials on Tumor-Agnostic Cancer Therapies During ESMO
3
With New OUD Diagnoses on the Rise, More Comprehensive Screenings Needed
4
Texas Sues J&J, Kenvue for Alleged Deception in Acetaminophen Marketing
5
